Why is "CDKL5" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-04-17 08:56:40
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Cyclin-dependent kinase-like 5 (CDKL5) is a serine/threonine protein kinase that in humans is encoded by the CDKL5 gene. It is critically involved in early brain development and function, particularly in neuronal maturation and synaptic regulation. Mutations in CDKL5 are associated with CDKL5 deficiency disorder (CDD), a severe neurodevelopmental condition that manifests with early-onset epilepsy, developmental delay, and motor and cognitive impairment. CDKL5 is closely related to the cyclin-dependent kinase family and has been implicated in disorders such as Rett syndrome and other epileptic encephalopathies.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Current and Emerging Treatment Options for CDKL5 Deficiency Disorder - NeurologyLive
-
CDKL5 and Gene Therapy - CGTLive®
-
KCC2 activation during postnatal development alleviates long-term deficits in CDKL5-deficient mice - Nature
-
Understanding the full impact of CDKL5 deficiency disorder - UCB
-
Seizure Progression and Management in CDKL5 Deficiency Disorder - NeurologyLive
-
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder - PR Newswire
-
Tenacia Biopharmaceuticals and Golden Age Health Partner to Commercialize ZTALMY - Business Wire
-
Jainu Jogani on the Potential to Address CDKL5 Deficiency With Gene Therapy - CGTLive®
-
UCB pursues approval of Fintepla in CDKL5 deficiency following Phase III study - Clinical Trials Arena
-
Phase III GEMZ Trial Meets Primary Endpoint for Fenfluramine in CDKL5 Deficiency Disorder - Applied Clinical Trials Online
-
Thinwa Receives CDKL5 Program of Excellence Pilot Grant: DOCS News - UT Southwestern Medical Center
-
Is highly purified cannabidiol a treatment opportunity for drug-resistant epilepsy in subjects with typical Rett syndrome and CDKL5 deficiency disorder? - Wiley Online Library
-
UCB presents positive results for fenfluramine in CDKL5 deficiency disorder - Pharmafile
-
Multidisciplinary Care in CDKL5 Deficiency Disorder - NeurologyLive
-
UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder - PR Newswire
-
Early Genetic Testing Key in Suspected CDKL5 Without Definitive EEG Pattern - NeurologyLive
-
Survey identifies Fever-Related Seizure Reduction as Key Feature of CDKL5 Deficiency Disorder - NeurologyLive
-
AES Poster Shines Light on Positive Phase 3 GEMZ Study of Fenfluramine in CDKL5 Deficiency Disorder - NeurologyLive
-
Fenfluramine Meets End Points in Phase 3 GEMZ Study of CDKL5 Deficiency Disorder - NeurologyLive
-
CDKL5 Deficiency - 5 EYEWITNESS NEWS
-
Fast-rising UCB set to file for Fintepla approval in 3rd epileptic disorder after trial win - Fierce Pharma
-
Toddler Naps for 24 Hours Straight—Mom Reveals What Led to Rare Diagnosis - Newsweek
-
Engineered tRNAs efficiently suppress CDKL5 premature termination codons - Nature
-
Gut microbiota profile in CDKL5 deficiency disorder patients - Nature
-
Cell type-specific expression, regulation and compensation of CDKL5 activity in mouse brain | Molecular Psychiatry - Nature
-
Stephen Kent Prater - The Arkansas Democrat-Gazette
-
Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder - Nature
-
Cdkl5 mutant zebrafish shows skeletal and neuronal alterations mimicking human CDKL5 deficiency disorder - Nature
-
Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2.3, altering inactivation kinetics and neuronal excitability - Nature
-
Gut-Targeted Approach Explored for Seizure Control in CDD - EMJ
-
UCB shares promising results for fenfluramine in ultra-rare form of epilepsy - PMLiVE
-
A case of CDKL5 deficiency disorder with a novel intragenic multi-exonic duplication - Nature
-
CDKL5 sculpts functional callosal connectivity to promote cognitive flexibility | Molecular Psychiatry - Nature
-
CDKL5 variants - Neurology® Journals
-
Not Just Loss-of-Function Variations - Neurology® Journals
-
Altered NMDAR signaling underlies autistic-like features in mouse models of CDKL5 deficiency disorder - Nature
-
Researchers awarded $1.4 million to develop gene therapy for rare genetic condition - University of California - Davis Health
-
New treatment target found for CDKL5 deficiency disorder - News-Medical
-
A kinome-wide screen identifies a CDKL5-SOX9 regulatory axis in epithelial cell death and kidney injury - Nature
-
Epilepsy-Related CDKL5 Deficiency Slows Synaptic Vesicle Endocytosis in Central Nerve Terminals - Journal of Neuroscience
-
CDKL5 Deficiency Disorder Added to WHO International Classification of Diseases - NeurologyLive
-
CDKL5 deficiency disorder: clinical features, diagnosis, and management - The Lancet
-
ELPIS study brings hope to patients of rare genetic condition, CDD - Trinity College Dublin
-
Growth patterns in individuals with CDKL5 deficiency disorder - Wiley Online Library
-
Altered network and rescue of human neurons derived from individuals with early-onset genetic epilepsy - Nature
-
First report of Tunisian patients with CDKL5‐related encephalopathy - Charfi Triki - 2024 - Epilepsia Open - Wiley Online Library
-
Marinus Pharmaceuticals Announces U.S. Commercial Launch of ZTALMY® (ganaxolone) for Seizures Associated With CDKL5 Deficiency Disorder - ir.marinuspharma.com
-
CDKL5 Deficiency Augments Inhibitory Input into the Dentate Gyrus That Can Be Reversed by Deep Brain Stimulation - Journal of Neuroscience
-
AMPA Receptor Dysregulation and Therapeutic Interventions in a Mouse Model of CDKL5 Deficiency Disorder - Journal of Neuroscience
-
Soticlestat Decreases Motor Frequency in CDKL5 Deficiency Disorder, With Benefits in Dup15q Syndrome - NeurologyLive
-
Next Steps in Tackling CDKL5 Deficiency Disorder Following First Approval: Elia Pestana-Knight, MD - NeurologyLive
-
CDKL5 Deficiency Disorder Market to Witness Upsurge in Growth, Assesses DelveInsight | Key Companies in the Market - Jazz, Stoke, Epygenix, Zogenix, UCB Pharma, Takeda, Eisai, Longboard, Marinus - PR Newswire
-
Research collaboration focuses on CDKL5 Deficiency Disorder - Baylor College of Medicine | BCM
-
Ganaxolone Meets Primary End Point in CDKL5 Deficiency Disorder Study - NeurologyLive
-
Perirhinal cortex abnormalities impair hippocampal plasticity and learning in Scn2a Fmr1 , and Cdkl5 autism mouse models - Science | AAAS
-
Research Suggests CDKL5 Deficiency Could Be Treated in Adulthood - Inside Precision Medicine
-
Supporting International CDKL5 Day - UCB
-
Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications - Nature
-
Pioneering researchers raise awareness of rare brain disorder in children - Trinity College Dublin
-
Ganaxolone’s Significant Effect on CDKL5 Deficiency Disorder: Elia Pestana-Knight, MD - NeurologyLive
-
Ztalmy Approved for CDKL5 Deficiency Disorder - Medical Professionals Reference
-
Ganaxolone: A Treatment for Major Motor Seizures in CDKL5 Deficiency Disorder - Neurology Advisor
-
Epileptic Disorders - Hypermotor-tonic-spasms seizure sequence related to CDKL5 deficiency disorder: a typical case - jle.com
-
mGluR5 PAMs rescue cortical and behavioural defects in a mouse model of CDKL5 deficiency disorder - Nature
-
'I knew something wasn't right': Baby's journey to rare diagnosis after 30 seizures a day - NZ Herald
-
Fenfluramine Shows Potential in CDKL5 Deficiency Disorder - NeurologyLive
-
Ganaxolone Effective for Rare Form of Childhood Epilepsy - Cleveland Clinic
-
Palmitoylation-dependent CDKL5–PSD-95 interaction regulates synaptic targeting of CDKL5 and dendritic spine development - PNAS
-
Ztalmy Oral Suspension Now Available for CDKL5 Deficiency Disorder - Medical Professionals Reference
-
MHRA approves Marinus Pharmaceuticals’ Ztalmy for CDKL5 deficiency disorder - PharmaTimes
-
New CDKL genes linked to neurodevelopmental disorders - Texas Children’s
-
Rarebase is on the hunt for therapeutic opportunities - Illumina
-
Devastating genetic disease in children may be treatable in adulthood - News-Medical
-
Genetic disease CDKL5 deficiency disorder could be treatable after childhood - Penn Today
-
Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder - Devinsky - 2021 - Epilepsia - Wiley Online Library
-
New Hope for Treating Epilepsy: Researchers Target "Lost" Enzyme - Inside Precision Medicine
-
New collaborative effort focuses on therapeutic research for CDKL5 Deficiency Disorder - News-Medical
-
Ganaxolone Now Available After Winning Landmark Approval for CDKL5 Deficiency Disorder - NeurologyLive
-
Marinus launches drug for seizures linked to CDKL5 deficiency disorder - Healio
-
Recurrent occurrences of CDKL5 mutations in patients with epileptic encephalopathy - Nature
-
Brain stimulation improves memory in autism mouse models - The Transmitter
-
Researchers identify new treatment target for genetic epilepsy - PharmaTimes
-
CDKL5 deficiency in forebrain glutamatergic neurons results in recurrent spontaneous seizures - Wiley Online Library
-
EC approves ZTALMY for seizures associated with CDKL5 deficiency - Pharmaceutical Technology
-
CDKL5, a Protein Associated with Rett Syndrome, Regulates Neuronal Morphogenesis via Rac1 Signaling - Journal of Neuroscience
-
Valley family with special needs is given gift of a lifetime for their daughter - 12News
-
Epileptic Disorders - Diaper changing-induced reflex seizures in CDKL5-related epilepsy - jle.com
-
Recognizing CDKL5 Deficiency Disorder - News-Medical
-
CDKL5 Deficiency Disorder designated with new disease code in WHO medical classification list - News-Medical
-
What We Know and Would Like to Know about CDKL5 and Its Involvement in Epileptic Encephalopathy - Wiley Online Library
-
The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy - Nature
-
New CDKL genes linked to neurodevelopmental disorders - Baylor College of Medicine Blog Network -
-
How Knowledge About Seizures Can Help End CDKL5 Epilepsy Stigma - The Mighty. Making health about people.
-
CDKL5 ensures excitatory synapse stability by reinforcing NGL-1–PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons - Nature
-
Amicus spends $90M on MiaMed; gains rare disease preclinical program - Fierce Biotech
-
Suffering in the shadows: What parents of medically complex children face every day — and night - CBC
-
MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome - Nature
-
Marinus’ Ztalmy Approved for CCD-Related Seizures - Inside Precision Medicine
-
Using New Genetic Therapies & Sleep Expertise to Advance Epilepsy Treatment & Research - NYU Langone Health
-
Harper's legacy: Family donates 5-year-old's brain to science after death from rare condition - Fox News
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.